Wedbush Reiterates Outperform on Quanex (NX) Following 2Q Report
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Needham Starts NeoVolta (NEOV) at Buy
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
Imperial Capital Reiterates Outperform on Quanex (NX) Following 2Q Earnings Report
June 2, 2016 7:16 AM EDTImperial Capital maintained an Outperform rating and $25.00 price target on Quanex Building Products (NYSE: NX) following the company's 2Q earnings report. Adjusted EPS of $0.10 for 2Q16 exceeded the consensus estimate of $0.08. Revenue exceeded Imperial's estimate by $5.5mn.
Analyst Scott Levine commented, "We are... More
After-Hours Stock Movers 05/31: (ZOES) (BYD) (SRPT) Higher; (ADPT) (ASNA) (UA) (BABA) Lower (more...)
May 31, 2016 5:55 PM EDTToday's After-Hours Movers:
Adeptus Health Inc. (NYSE: ADPT) 8.3% LOWER; announced the offering of 2,750,000 shares of its Class A common stock, of which 1,843,162 shares are to be sold by the Company, and 906,838 shares are to be sold by an affiliate of Sterling Partners (the "Selling Stockholder"). The Company intends to use all of the net proceeds from the offering received by it to purchase, for cash, 1,843,162 limited liability company units of Adeptus Health LLC, its direct subsidiary, from certain of the unit holders of Adeptus Health LLC, including... More
Quanex (NX) Tops Q2 EPS by 1c, Updates FY Guidance
May 31, 2016 4:21 PM EDTQuanex (NYSE: NX) reported Q2 EPS of $0.10, $0.01 better than the analyst estimate of $0.09. Revenue for the quarter came in at $229.5 million versus the consensus estimate of $228.86 million.
GUIDANCE:
Quanex sees FY2016 EPS of $0.78-$0.87, versus the consensus of $0.83. Quanex sees... More
